Skip to content

Zone 2 Cardio

Overview

Zone 2 cardio refers to low-intensity aerobic exercise performed below the lactate threshold — the intensity at which the body can still clear lactate as fast as it is produced. In practical terms, this is the intensity at which a patient can hold a conversation but would prefer not to (RPE 11–13 on the Borg scale). While popular media has enthusiastically promoted Zone 2 training as the "optimal" intensity for mitochondrial health and longevity, a 2025 narrative review in Sports Medicine by Storoschuk et al. challenges this consensus, arguing that higher intensities produce superior cardiometabolic adaptations at lower training volumes. For cardiac rehabilitation, Zone 2 remains the safest starting point for aerobic exercise prescription, particularly in Phase II–III, but it should be understood as a foundation rather than a ceiling. ^[raw/AHA_ACC_AACVPR_2024_Core_Components.md]

Key Facts

  • Modality type: Aerobic endurance
  • Intensity range: Below lactate threshold; approximately 60–70% of HRR or 55–65% of HRmax (unmedicated)
  • Primary claimed benefits: Enhanced mitochondrial capacity, improved fatty acid oxidation, metabolic flexibility, cardiovascular base
  • Contested claim: A 2025 review in Sports Medicine found that Zone 2 is NOT uniquely superior for mitochondrial adaptations — higher intensities produce greater cardiometabolic benefit per unit of time ^[raw/Optimizing_Exercise_Volume_for_Secondary_Prevention.md]
  • Phase applicability: Phase II (foundational) through Phase IV (maintenance base)
  • Evidence grade: High for safety in CR; medium for the "Zone 2 is optimal" claim specifically

Defining Zone 2

By Heart Rate (Karvonen Formula)

Zone 2 corresponds to approximately 60–70% of Heart Rate Reserve:

Target HR = Resting HR + (0.60 to 0.70) × (HRmax - Resting HR)

For a patient with resting HR 65 and age-predicted HRmax 170: - Zone 2 range: 65 + 0.60×(170-65) to 65 + 0.70×(170-65) = 128–138 bpm

By RPE (Preferred for Beta-Blocker Patients)

  • RPE 11–13 on the Borg 6–20 scale ("light" to "somewhat hard")
  • Conversation test: patient can speak in complete sentences but would prefer not to

By Lactate (Research Setting)

  • Blood lactate < 2 mmol/L
  • This is the gold standard definition but impractical in clinical CR settings

The Zone 2 Debate

Zone 2 training is widely promoted (particularly in longevity-focused media) as uniquely optimal because: - It maximizes fat oxidation as a fuel source - It preferentially stimulates mitochondrial biogenesis - It can be sustained for long durations without excessive fatigue - It produces minimal oxidative stress and inflammation

The Counter-Argument (Storoschuk et al., Sports Medicine, 2025)

  • Elite athlete data ≠ general population: Much of the Zone 2 evidence comes from observational studies of elite endurance athletes who already possess extraordinary mitochondrial capacity. Findings from this specialized group should not be broadly generalized.
  • Not optimal for mitochondrial adaptations: Current evidence does not support Zone 2 as the optimal intensity for improving mitochondrial or fatty acid oxidative capacity in the general population.
  • Higher intensities are superior per unit time: For individuals with limited time (the majority of cardiac patients), higher-intensity exercise (>Zone 2) delivers greater cardiometabolic benefit per minute of training.

Clinical Position for Cardiac Rehabilitation

  • Zone 2 is the safest starting point for aerobic exercise in Phase II–III CR
  • Patients should progress beyond Zone 2 as fitness improves — the goal is not to stay in Zone 2 indefinitely
  • Hybrid programming (Zone 2 base + periodic higher-intensity intervals, such as [[japanese-interval-walking]]) likely offers the best risk-benefit ratio

Cardiac Application and Dosage

Phase-Based Prescription

Phase Zone 2 Duration Frequency Modality Supervision
Phase II 10–20 min (build from 5 min) 3–5×/wk Walking, recumbent cycling, rowing Continuous telemetry initially
Phase III 20–40 min 4–5×/wk Rowing, cycling, swimming, walking Spot-check
Phase IV 30–60 min 3–5×/wk Any preferred modality Self-monitored

Progression Rule

Follow the duration-first progression model: 1. Increase session duration by 5 min/week until reaching 30–40 min 2. Then increase frequency (if below 5×/wk) 3. Then consider intensity progression (add interval components or increase steady-state intensity)

Hemodynamic Safety

  • Sustained BP elevation: Unlike interval training, Zone 2 produces a sustained (not spiked) BP response. Patients with uncontrolled hypertension should begin at the lower end of the Zone 2 range.
  • HR drift: Cardiac drift (gradual HR increase during prolonged steady-state exercise) is normal. If HR exceeds the Zone 2 ceiling by >5 bpm for >5 min, reduce intensity.
  • Beta-blocker considerations: HR targets are unreliable on beta-blockers. Use RPE exclusively for intensity calibration.

Benefits for the Over-50 Cardiac Patient

  • Aerobic base building: Zone 2 establishes the cardiovascular foundation necessary for higher-intensity training — patients who skip this base are at higher injury and cardiac event risk when they progress.
  • Fat oxidation: At Zone 2 intensities, the body preferentially uses fat as fuel — relevant for weight management, which is a core component of secondary prevention.
  • Recovery-friendly: Zone 2 exercise can be performed daily without excessive fatigue, supporting the high-frequency prescription that drives volume targets.
  • Low perceived exertion: Patients find Zone 2 tolerable, which supports adherence — the best exercise prescription is the one the patient actually follows.
  • [[aerobic-exercise-prescription]] — Karvonen formula, HRR, Borg RPE; the framework for Zone 2 prescription
  • [[exercise-volume-secondary-prevention]] — How Zone 2 contributes to the 1000/1500/2200 kcal/wk targets
  • [[japanese-interval-walking]] — Higher-intensity complement to Zone 2 base training
  • [[low-impact-cardio-modalities]] — Modalities suitable for Zone 2 training
  • [[beta-blockers-exercise-prescription]] — HR target reliability on rate-limiting medications